Key Figures
Key Figures for the First Half of 2020
| Group | Bioprocess Solutions | Lab Products & Services | ||||||||||
| in millions of € unless otherwise specified | 6-mo. 2020 | 6-mo. 2019 | Δ in % reported | Δ in % cc1 | 6-mo. 2020 | 6-mo. 2019 | Δ in % reported | Δ in % cc1 | 6-mo. 2020 | 6-mo. 2019 | Δ in % reported | Δ in % cc1 |
| Sales Revenue and Order Intake | ||||||||||||
| Order intake | 1,244.8 | 974.3 | 27.8 | 27.5 | 984.9 | 735.6 | 33.9 | 33.5 | 259.9 | 238.8 | 8.9 | 8.9 |
| Sales revenue | 1,056.8 | 894.7 | 18.1 | 17.9 | 809.3 | 665.8 | 21.6 | 21.3 | 247.5 | 228.9 | 8.1 | 8.1 |
| EMEA2 | 419.5 | 362.0 | 15.9 | 16.0 | 310.9 | 263.9 | 17.8 | 17.9 | 108.6 | 98.0 | 10.8 | 11.0 |
| Americas2 | 373.1 | 308.2 | 21.1 | 19.7 | 304.8 | 246.2 | 23.8 | 22.2 | 68.3 | 62.0 | 10.2 | 9.7 |
| Asia | Pacific2 | 264.2 | 224.5 | 17.7 | 18.4 | 193.7 | 155.7 | 24.4 | 25.5 | 70.5 | 68.8 | 2.4 | 2.5 |
| Results | ||||||||||||
| EBITDA3 | 293.5 | 237.6 | 23.5 | 247.2 | 191.5 | 29.1 | 46.4 | 46.2 | 0.4 | |||
| EBITDA-Margin3 in % | 27.8 | 26.6 | 30.5 | 28.8 | 18.7 | 20.2 | ||||||
| Net result4 | 124.3 | 101.5 | 22.4 | |||||||||
| Financial data per share | ||||||||||||
| Earnings per ordinary share4 in € | 1.81 | 1.48 | 22.5 | |||||||||
| Earnings per preference share4 in € | 1.82 | 1.49 | 22.3 | |||||||||
| June 30, 2020 | Dec. 31, 2019 | |
| Balance Sheet | Financials | ||
| Balance sheet total | 3,850.4 | 2,868.5 |
| Equity | 1,157.4 | 1,093.2 |
| Equity ratio in % | 30.1 | 38.1 |
| Net debt | 1,669.6 | 1,014.0 |
| Net debt to underlying EBITDA | 2.8 | 2.1 |
1 In constant currencies
2 Acc. to customers' loaction
3 Adjusted for extraordinary items
4 After non-controlling interest, adjusted for extraordinary items and non-cash amortization, and based on the normalized financial result and tax rate.
Key Figures for the Second Quarter of 2020
| Group | Bioprocess Solutions | Lab Products & Services | ||||||||||
| in millions of € unless otherwise specified | Q2 20201 | Q2 20191 | Δ in % reported | Δ in % cc2 | Q2 20201 | Q2 20191 | Δ in % reported | Δ in % cc2 | Q2 20201 | Q2 20191 | Δ in % reported | Δ in % cc2 |
| Sales Revenue and Order Intake | ||||||||||||
| Order intake | 615.4 | 491.5 | 25.2 | 25.3 | 478.8 | 374.9 | 27.7 | 27.7 | 136.6 | 116.6 | 17.1 | 17.7 |
| Sales revenue | 546.9 | 459.0 | 19.1 | 19.2 | 415.0 | 345.1 | 20.3 | 20.2 | 131.9 | 113.9 | 15.8 | 16.1 |
| EMEA3 | 212,5 | 184.0 | 15.5 | 157.1 | 136.2 | 15.3 | 55.4 | 47.8 | 16.0 | |||
| Americas3 | 192.5 | 155.8 | 23.5 | 155.0 | 124.3 | 24.7 | 37.4 | 31.5 | 18.7 | |||
| Asia | Pacific3 | 141.9 | 119.2 | 19.1 | 102.9 | 84.6 | 21.6 | 39.0 | 34.6 | 12.9 | |||
| Results | ||||||||||||
| EBITDA4 | 155.7 | 123.6 | 25.9 | 127.3 | 100.6 | 26.6 | 28.4 | 23.0 | 23.2 | |||
| EBITDA-Margin4 in % | 28.5 | 26.9 | 30.7 | 29.1 | 21.5 | 20.2 | ||||||
| Net result5 | 68.0 | 52.9 | 28.5 | |||||||||
| Financial Data per Share | ||||||||||||
| Earnings per ordinary share5 in € | 0.98 | 0.77 | 27.0 | |||||||||
| Earnings per preference share5 in € | 0.98 | 0.77 | 27.0 | |||||||||
1 Figures are not audited nor reviewed
2 In constant currencies
3 Acc. to customers' loaction
4 Adjusted for extraordinary items
5 After non-controlling interest, adjusted for extraordinary items and non-cash amortization, and based on the normalized financial result and tax rate.